Avadel Pharma (AVDL) Misses Q2 EPS by 47c

Avadel Pharma (NASDAQ: AVDL) reported Q2 EPS of ($0.83), $0.47 worse than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Avadel Pharma (AVDL) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• FedEx (FDX) PT Lowered to $424 at Bernstein SocGen Group
• Alphabet slides over 6% as AI brain drain and SpaceX slump converge